Clinical Research Directory
Browse clinical research sites, groups, and studies.
The TRICURE First in Human Trial
Sponsor: TRiCares
Summary
The objective of this first in human study is to gain early clinical insight into the safety profile and performance of the Topaz transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding bioprosthetic valve within the tricuspid valve.
Official title: TRiCares Topaz Transfemoral Tricuspid Heart Valve Replacement System First in Human Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2022-07-15
Completion Date
2029-05-15
Last Updated
2025-03-26
Healthy Volunteers
No
Conditions
Interventions
Topaz TTVR System
Transcatheter tricuspid heart valve replacement
Locations (11)
Algemeen Stedelijk Ziekenhuis,
Aalst, Belgium
ZNA Middelheim
Antwerp, Belgium
Cliniques Universitaires Saint-Luc UCL
Brussels, Belgium
Centre hospitalier universitaire CHU de Liège
Liège, Belgium
CHU Bordeaux
Bordeaux, France
Hospices Civils de Lyon, Hôpital Cardiothoracique Louis Pradel
Bron, France
CHU Henri Mondor
Créteil, France
University Hospital Lille, Institut Cœur Poumon
Lille, France
Hôpital Saint Joseph
Marseille, France
CHU Pontchaillou
Rennes, France
Centre Cardiologique du Nord
Saint-Denis, France